Leadership & Pay ·
Akebia Therapeutics CCO Nicholas Grund resigns effective November 6
AKBAAkebia Therapeutics, Inc.
Nicholas Grund, Senior Vice President and Chief Commercial Officer of Akebia Therapeutics, Inc., notified the company on October 7, 2026, that he is resigning from his employment for personal reasons. The resignation becomes effective on November 6, 2026. In connection with this departure, Grund entered into a consulting agreement on October 13, 2026, to provide advisory services until April 30, 2027, at an hourly rate. Akebia Therapeutics operates in the biopharmaceutical industry.